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The pathogenesis of inflammatory bowel dis-
ease  (IBD)  involves  the  presence  of  one  or 
more genetically determined defects that result 
in an abnormal mucosal immune system that 
overreacts to normal constituents of the micro-
biota (Elson et al., 2005; Sartor, 2006; Strober 
et al., 2007). The complex intestinal microbiota 
provides an abundant source of immunostimula-
tory organisms containing innate stimulatory 
materials and antigens that can activate innate 
and adaptive immune responses, respectively. 
In multiple experimental models of colitis, the 
microbiota plays a crucial role, in that the mice 
develop colitis with a conventional microbiota 
but fail to develop colitis when housed under 
germfree conditions (Taurog et al., 1994; Rath 
et al., 1996; Sellon et al., 1998; Frank et al., 
2007). It is now generally accepted that com-
mensal enteric bacteria provide constant anti-
genic stimulation that can activate pathogenic 
T cells and lead to chronic intestinal inflamma-
tion. Data from our own studies and others 
suggest that an excessive adaptive immune re-
sponse to gut microflora antigens is indispens-
able for intestinal inflammation (Lodes et al., 
2004; Xavier and Podolsky, 2007). Transfer of 
CD4+ T cells reactive to a single commensal 
flagellin antigen or to a single bacteria-associated 
antigen is able to induce colitis development 
in immunodeficient mice (Iqbal et al., 2002; 
Lodes et al., 2004; Watanabe et al., 2006). All 
the subsets of CD4+ effector T cells reactive to 
commensal bacterial antigens have been impli-
cated in the pathogenesis of IBD. IFN-–Th1 
and IL-23/IL-17–Th17 pathways are associated 
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Little is known about how the microbiota regulates T cell proliferation and whether  
spontaneous T cell proliferation is involved in the pathogenesis of inflammatory bowel 
disease. In this study, we show that stimulation of innate pathways by microbiota-derived 
ligands and antigen-specific T cell stimulation are both required for intestinal inflammation. 
Microbiota-derived ligands promoted spontaneous T cell proliferation by activating  
dendritic cells (DCs) to produce IL-6 via Myd88, as shown by the spontaneous proliferation 
of T cells adoptively transferred into specific pathogen–free (SPF) RAG/ mice, but not in 
germfree RAG/ mice. Reconstitution of germfree RAG/ mice with cecal bacterial  
lysate–pulsed DCs, but not with IL-6/ or Myd88/ DCs, restored spontaneous T cell 
proliferation. CBir1 TCR transgenic (CBir1 Tg) T cells, which are specific for an immuno-
dominant microbiota antigen, induced colitis in SPF RAG/ mice. Blocking the spontaneous 
proliferation of CBir1 Tg T cells by co-transferring bulk OT II CD4+ T cells abrogated colitis 
development. Although transferred OT II T cells underwent spontaneous proliferation in 
RAG/ mice, the recipients failed to develop colitis because of the lack of cognate antigen 
in the intestinal lumen. Collectively, our data demonstrate that induction of colitis requires 
both spontaneous proliferation of T cells driven by microbiota-derived innate signals and 
antigen-specific T cell proliferation.
© 2010 Feng et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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In this study, we investigated the effect of the microbiota 
on T cell spontaneous proliferation and the role of T cell 
spontaneous proliferation in the pathogenesis of intestinal in-
flammation. A mouse TCR transgenic line (CBir1 Tg) which 
is specific for the immunodominant microbiota flagellin anti-
gen, CBir1, present in the intestinal lumen (Cong et al., 
2009), as well as a TCR transgenic line (OT II) specific for 
ovalbumin which is not present in the intestinal lumen was 
used. We demonstrate that the microbiota provided innate 
stimulatory activity to promote T cell spontaneous prolifera-
tion by activating DCs to produce IL-6 via TLR–TLR li-
gand interaction through a Myd88-dependent pathway. Both 
microbiota innate stimulation-driven T cell spontaneous pro-
liferation and microbiota-induced antigen-specific T cell ac-
tivation were required for the induction of colitis.
RESULTS
Transfer of CBir1 Tg CD4+ T cells, but not OT II CD4+ T cells, 
induces colitis in B6.RAG/ mice under SPF conditions
To determine the role of commensal bacterial antigens in in-
duction of colitis in lymphopenic mice, 106 CD4+ T cells 
from B6.CBir1 Tg mice specific for a microbiota flagellin 
present in intestinal lumen and CD4+ T cells from B6.OT II 
mice specific for OVA were separately transferred into spe-
cific pathogen–free (SPF) B6.RAG/ mice. RAG/ re-
cipients of CBir1 Tg CD4+ T cells, but not OT II CD4+ 
T cells, lost weight starting from week 3 (Fig. 1 A). All recipi-
ents that received CBir1 Tg CD4+ T cells developed severe 
colonic inflammation when sacrificed 8 wk after cell transfer. 
In contrast, none of the recipients that received OT II CD4+ 
T cells developed colitis (Fig. 1, B–D), indicating that activa-
tion by cognate antigen in the intestine plays a crucial role in 
the induction of colitis. Both CBir1 Tg CD4+ T cells and 
OT II CD4+ T cells proliferated, and substantial numbers of 
CD4+ T cells were recovered from the intestinal lamina pro-
pria (LP) of recipients. Notably, more LP CD4+ T cells were 
recovered from the RAG/ recipients of CBir1 Tg CD4+ 
T cells (3.2 × 105/mouse) than from the recipients of OT II 
CD4+ T cells (1 × 105/mouse). Th1 and Th17 cells have been 
implicated  in  the  induction  of  colitis  in  various  animal 
models of colitis and in patients with IBD (Cong et al., 2002; 
Iqbal et al., 2002; Hue et al., 2006; Kullberg et al., 2006; 
Elson et al., 2007; Kobayashi et al., 2008; Brand, 2009; 
Zenewicz et al., 2009). To determine if there is different cy-
tokine production in the recipients reconstituted with CBir1 
Tg CD4+ T cells vs. with OT II CD4+ T cells, LP CD4+ 
T cell production of IFN- and IL-17 was determined by 
flow cytometry 8 wk after cell transfer. LP CD4+ T cells from 
the recipients of OT II T cells produced IFN- (8.69%) and 
IL-17 (4.14%) at a low frequency, whereas LP CD4+ T cell 
from the recipients of CBir1 Tg T cells produced IFN- 
(21.2%) and IL-17 (17.0%) at a much higher frequency. In-
terestingly, a substantial proportion of IL-17+IFN-+ double 
positive LP CD4+ T cells were present in colitic RAG/ 
recipient mice reconstituted with CBir1 Tg T cells but not 
in OT II T cell reconstituted recipients (Fig. 1 E). Whether 
with Crohn’s disease, whereas the IL-13–Th2 pathway is as-
sociated with ulcerative colitis. It has also been shown that 
microbial components are necessary for the onset of abnor-
mal inflammatory responses because of their capacity to 
stimulate innate cells via membrane-bound and endosomal 
Toll-like receptors (TLRs). TLR4 deficiency abrogates colitis 
development in myeloid-specific signal transducer and acti-
vator of transcription (STAT)-3/ mice (Kobayashi et al., 
2003) and Myd88 deficiency blocks colitis development in 
IL-10–deficient mice (Rakoff-Nahoum et al., 2006). How-
ever, the mechanism by which the Myd88 pathway supports 
intestinal inflammation is still largely unknown. It is also un-
known whether microbiota stimulation of innate responses 
via TLR ligands and adaptive immune responses to microbi-
ota antigens contributes to intestinal inflammation indepen-
dently or whether they interact with another.
Homeostatic mechanisms control the overall size and 
composition of the mature T cell pool to keep the overall 
number of T cells relatively constant during life (Jameson, 
2002; Min et al., 2005; Surh and Sprent, 2008). Accumu-
lating data indicate a role for T cell homeostatic proliferation 
in the pathogenesis of autoimmune diseases (Theofilopoulos 
et al., 2001; King et al., 2004; Krupica et al., 2006; Milner 
et al., 2007; Chang et al., 2008; McPherson et al., 2009), as 
well as in controlling HIV reservoir size and persistence in 
latently infected CD4+ T cells (Chomont et al., 2009). In 
response to lymphopenia, naive T cells proliferate and tran-
sition into a memory-like state through a process termed 
“homeostatic proliferation” (Jameson, 2002). T cell homeo-
stasis is regulated by two distinct modes of cell prolifera-
tion: slow IL-7/IL-15-dependent homeostatic proliferation 
and rapid MHC/antigen interaction-dependent spontane-
ous proliferation (Schluns et al., 2000; Ku et al., 2000; 
Goldrath et al., 2002, 2004; Min et al., 2004). A recent 
work demonstrates that IL-6 is responsible for spontane-
ous proliferation in an adoptive transfer model of colitis, 
in that blockade of IL-6 inhibited CD8+ T cell spontane-
ous proliferation as well as colitis development in RAG/ 
recipient mice (Tajima et al., 2008). However, the factors 
that stimulate IL-6 production, the cellular source of IL-6, 
and the exact role of IL-6 in T cell spontaneous prolifera-
tion are still unknown. The intestinal microbiota has been 
shown to be required for T cell spontaneous proliferation. 
Germfree mice have underdeveloped mucosal and systemic 
immune systems with decreased cellularity of gut associ-
ated lymphoid tissues, mesenteric lymph nodes, and spleen 
(Cebra, 1999; Mazmanian et al., 2008). Adoptively trans-
ferred polyclonal CD4+ T cells do not undergo spontaneous 
proliferation in germfree SCID mice but do in conven-
tionally reared SCID mice (Kieper et al., 2005). However, 
it is unclear whether the microbiota-driven T cell spontane-
ous proliferation is caused by microbiota antigenic stimulation 
or their interaction with host innate cells via TLR–TLR 
ligand interactions, and whether microbiota-driven T cell 
spontaneous  proliferation  is  required  for  the  induction   
of colitis.JEM VOL. 207, June 7, 2010 
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such IL-17+IFN-+ CD4+ T cells are the pathogenic T cells 
that drive colitis development is unclear at present.
To investigate whether lack of colitis induction in the 
RAG/ recipient mice that received OT II T cells was 
caused by significantly less proliferation of OT II T cells than 
CBir1 Tg T cells upon transfer into RAG/ mice and inde-
pendent of antigen recognition, 5 × 106 naive or OT II 
CD4+ T cells that had been activated with OVA for a week 
were transferred into SPF B6.RAG/ mice, and the recipi-
ent mice were then colonized with OVA-expressing Esche-
richia coli (OVA-E. coli) or irrelevant Tetanus toxin fragment 
C (TET)–expressing E. coli (TET-E. coli). When sacrificed 
8 wk later, neither naive nor preactivated OT II T cells 
induced  colitis  in  the  recipients  colonized  with  TET- 
expressing E. coli (Fig. 1 F), but all recipients colonized with 
OVA-expressing E. coli did develop colitis with a pathology 
score of 64 ± 21 (Fig. 1 G), indicating that lack of colitis in 
the OT II T cell recipients was not caused by the number of 
OT II T cells, but by lack of cognate antigen in the colon. 
Collectively, these data demonstrated a crucial role of bacte-
rial-associated antigens in the induction of colitis.
To determine whether the inability of OT II T cells to 
induce colitis in the RAG/ recipients is caused in part by 
the  lack  of  homeostatic  proliferation  and/or  spontaneous 
proliferation of OT II T cells in RAG/ mice, CBir1 Tg 
CD4+ T cells and OT II CD4+ T cells were labeled with 
CFSE  and  transferred  separately  into  RAG/  mice.  As 
shown in Fig. 2, both CBir1 Tg CD4+ T cells and OT II 
CD4+ T cells underwent homeostatic proliferation and spon-
taneous proliferation. Approximately 43% of OT II T cells 
Figure 1.  Adoptive transfer of CBir1 Tg 
CD4+ T cells but not OT II CD4+ T cells 
induces colitis in RAG/ mice. Groups of 5 
B6.RAG/ mice were injected with 106 CBir1 
Tg CD4+ T cells, 106 OT II CD4+ T cells, or PBS 
as control. Recipient mice were weighed 
weekly. 8 wk after transfer, the mice were 
sacrificed and assessed for histopathology.  
LP CD4+ T cell cytokine production was  
determined by flow cytometry. (A) Weight 
changes of the recipient mice. *, P < 0.05 
compared with the PBS group. (B) Pathologi-
cal scores of the recipient mice. **, P < 0.01 
compared with the PBS group. (C and D) Co-
lonic histopathology of the recipient mice.  
(E) Intestinal LP CD4+ T cell IL-17 and IFN- 
production. (F and G) Groups of 5 B6.RAG/ 
mice were injected with 5 × 106 OT II CD4+ T 
cells and then intrarectally administered with 
TET-E. coli (F) or with OVA-E. coli (G) every 
week. Data are from one of two independent 
experiments with similar results. Bars: (C, D, 
and F) 50 μm; (E) 100 μm.
Figure 2.  More CBir1 Tg CD4+ T cells undergo spontaneous prolif-
eration than do OT II CD4+ T cells in RAG/ mice. 106 CFSE-CBir1 Tg 
CD4+ T cells or 106 CFSE-OT II CD4+ T cells were transferred into RAG/ 
mice, and the recipient mice were sacrificed 10 d later. CD4+ T cell prolifera-
tion in the spleen was analyzed by CFSE dilution by flow cytometry. (A) OT II 
CD4+ T cell proliferation in RAG/ mice. (B) CBir1 Tg CD4+ T cell prolifera-
tion in RAG/ mice. Numbers in each plot represent the percentage of 
donor cells undergoing spontaneous proliferation, homeostatic prolifera-
tion, and staying undivided, respectively. Data are representative of at least 
four individual mice of each group from three independent experiments.  
(C) Percentage of transferred T cells in spontaneous proliferation (SP), ho-
meostatic proliferation (HP), and undivided from three independent experi-
ments. *, P < 0.05 for CBir1 Tg T cells against OT II T cells.1324 Microbiota innate stimulation in colitis | Feng et al.
proliferation was determined by flow 
cytometry  based  on  CFSE  dilution. 
As previously shown, CBir1 Tg CD4+ 
T cells and OT II CD4+ T cells un-
derwent  both  homeostatic  prolifera-
tion and spontaneous proliferation in 
SPF RAG/ mice (Fig. 3, A and F), 
whereas both TCR Tg T cells under-
went  only  homeostatic  proliferation,  but  not  spontaneous 
proliferation, in RAG/ mice housed in germfree condi-
tions (Fig. 3, B and G). Interestingly, both TCR Tg T 
cells underwent homeostatic proliferation and spontaneous 
proliferation in RAG/ mice reconstituted with Altered 
Schaedler’s Flora (ASF; Fig. 3, C and H). As previously 
shown, CBir1 Tg T cells induced colitis in SPF RAG/ 
mice, but not in germfree RAG/ mice, 8 wk after cell 
transfer (Fig. 3, D and E). These data are consistent with an-
tigenic stimulation by the microbiota driving T cell sponta-
neous proliferation, as previously suggested (Kieper et al., 
2005; Surh and Sprent, 2008); however, they do not exclude 
a role for microbiota innate stimulation in T cell spontane-
ous proliferation.
Microbiota stimulation of DC IL-6 production via Myd88 
promotes T cell spontaneous proliferation
To determine whether microbiota-DC interactions affect 
T cell homeostatic proliferation and/or spontaneous prolifer-
ation, RAG/.OT II CD4+ T cells were transferred into 
germfree  RAG/  mice  together  with  BM-derived  DCs 
(BMDCs) that were or were not pulsed with cecal bacterial 
lysates (CBLs) from conventional SPF mice. RAG/.OT II 
CD4+ T cells underwent only homeostatic proliferation in 
the RAG/ recipients reconstituted with control PBS-
pulsed BMDCs (Fig. 4 A). However, they underwent both 
underwent spontaneous proliferation, 11.8% underwent homeo-
static proliferation, and 45.3% remained undivided (Fig. 2, 
A and C). A higher proportion of CBir1 Tg CD4+ T cells 
underwent spontaneous proliferation (Fig. 2, B and C). Approx-
imately 72.9% of CBir1 Tg T cells underwent spontaneous 
proliferation, 6.18% underwent homeostatic proliferation, and 
20.9% stayed undivided (Fig. 2 B). This could be caused by 
differences of TCR affinity between OT II T cells and CBir1 
Tg T cells, or by the presence of CBir1 flagellin, but not OVA, 
in the intestine, which could further stimulate CBir1 Tg T cell 
spontaneous proliferation.
CD4+ T cells do not undergo spontaneous proliferation  
in germfree RAG/ mice
In multiple experimental colitis models, mice do not develop 
colitis under germfree conditions. We next asked whether 
microbiota could affect colitis induction via regulation of 
T  cell  spontaneous  proliferation.  As  reported  previously 
(Cebra, 1999; Mazmanian et al., 2008), the total number of 
splenic CD4+ and CD8+ T cells in germfree mice are only 
80% of that of conventional SPF mice, indicating a mild 
lymphopenic condition. To further investigate the role of 
intestinal microbiota in T cell spontaneous proliferation, 
CFSE-labeled CBir1 Tg CD4+ T cells or OT II CD4+ T cells 
were transferred into RAG/ mice housed in conventional 
SPF conditions or in germfree conditions. 10 d later, T cell   
Figure 3.  CD4+ T cells do not undergo 
spontaneous proliferation in germfree 
RAG/ mice. 106 CFSE-CBir1 Tg CD4+ T cells 
(A–C) or 106 CFSE-OT II CD4+ T cells (F–H) 
were transferred into RAG/ mice housed 
under SPF conditions (A and F), germfree (GF) 
conditions (B and G), or ASF conditions (C and 
H). 10 d after the transfer, division of the 
CFSE-labeled CD4+ T cells was determined by 
CFSE dilution. Numbers in each plot represent 
the percentage of donor cells undergoing 
spontaneous proliferation, homeostatic prolif-
eration, and staying undivided, respectively. 
Data are representative of at least three indi-
vidual mice of each group from three indepen-
dent experiments. Histopathology of the colon 
of CBir1 Tg T cell recipients at 5 mice/group 
under SPF conditions (D) and germfree condi-
tions (E) was assessed 8 wk after cell transfer. 
Bars, 100 µm. Data are representative of three 
independent experiments with similar results.JEM VOL. 207, June 7, 2010 
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they only underwent homeostatic prolifera-
tion but not spontaneous proliferation in the 
recipients  reconstituted  with  CBL-pulsed 
IL-6/ BMDCs (Fig. 4 D), demonstrating 
that DC IL-6 production plays a crucial role 
in the CD4+ T cell spontaneous proliferation 
driven by the microbiota.
Multiple microbial products stimulate DC cytokine pro-
duction via TLR–TLR ligand interaction through Myd88 
(Medzhitov et al., 1998; Beutler, 2004; Akira et al., 2006; 
Medzhitov, 2007). To determine the role of Myd88 pathway 
in microflora-driven CD4+ T cell spontaneous proliferation 
in vivo, RAG/.OT-II CD4+ T cells were transferred 
into  germfree  RAG/  mice  together  with  CBL-pulsed 
Myd88/ BMDCs or control CBL-pulsed WT BMDCs. 
As shown previously, CD4+ T cells underwent homeostatic 
and spontaneous proliferation in the germfree RAG/ re-
cipient mice reconstituted with CBL-pulsed WT BMDCs. 
However, in the RAG/ recipient mice reconstituted with 
CBL-pulsed Myd88/ BMDCs, RAG/.OT II T cells 
only underwent homeostatic proliferation, but not spontaneous 
proliferation  (Fig.  4  E),  confirming  that  the  Myd88- 
dependent TLR pathway plays a crucial role in microbiota-
driven CD4+ T cell spontaneous proliferation through the 
induction of DC IL-6 production.
homeostatic proliferation and spontaneous proliferation in the 
RAG/ recipients reconstituted with CBL-pulsed BMDCs 
(Fig. 4 B), indicating that microbiota-stimulated DCs can 
result in nonspecific stimulation of CD4+ T cell spontaneous 
proliferation.
IL-6 has been shown to be a vital cytokine in CD8+  
T cell spontaneous proliferation in a recent study (Tajima 
et al., 2008). We next determined the role of IL-6 in the 
promotion of CD4+ T cell spontaneous proliferation by CBL-
pulsed DCs. CBL-pulsed BMDCs produced high amounts 
of IL-6, as well as TNF and IL-1 in vitro, and such IL-6 and 
other  cytokine  production  was  impaired  in  CBL-pulsed 
Myd88/ BMDCs, indicating that the Myd88 is involved 
in CBL-stimulated DC IL-6 production (Fig. 4 C). RAG/.
OT II CD4+ T cells were then transferred into germfree 
RAG/ mice together with WT or IL-6/ CBL-pulsed 
BMDCs. RAG/.OT II CD4+ T cells underwent both ho-
meostatic proliferation and spontaneous proliferation in the 
recipients reconstituted with CBL-pulsed WT BMDCs, whereas 
Figure 4.  Microbiota stimulation of DC IL-6 
production via Myd88 pathway promotes T cell 
spontaneous proliferation. BMDCs generated from 
B6 mice were pulsed with PBS or 100 µg/ml of CBLs 
for 24 h. 106 CFSE-RAG/.OT II CD4+ T cells were 
transferred together with 106 PBS-pulsed BMDCs (A) 
or with CBL-pulsed BMDCs (B) into germfree RAG/ 
mice. 10 d after the transfer, division of the CFSE-
labeled CD4+ T cells was determined by flow cytom-
etry. Numbers in each plot represent the percentage 
of donor cells undergoing spontaneous proliferation, 
homeostatic proliferation, and staying undivided, 
respectively. (C) BMDCs generated from B6 mice or 
B6.Myd88/ mice were stimulated with 100 µg/ml 
of CBL for 24 h. To determine IL-1 production, 2 
mM ATP was added in the last 10 min of the culture. 
IL-6, TNF, and IL-1 production in the supernatant 
was determined by ELISA. **, P < 0.01 compared with 
WT DCs. (D) 106 CFSE-RAG/.OT II CD4+ T cells were 
transferred together with 106 CBL-pulsed B6.BMDCs 
or CBL-pulsed B6.IL-6/ BMDCs into germfree 
RAG/ mice. (E) 106 CFSE-RAG/.OT II CD4+ T cells 
were transferred together with 106 CBL-pulsed 
B6.BMDCs or CBL-pulsed B6.Myd88/ BMDCs into 
germfree RAG/ mice. 10 d after the transfer,  
division of the CFSE-labeled CD4+ T cells was  
determined by flow cytometry. Numbers in each plot 
represent the percentage of donor cells undergoing 
spontaneous proliferation, homeostatic proliferation, 
and undivided, respectively. Data are representative 
of at least four mice of each group from two  
independent experiments.1326 Microbiota innate stimulation in colitis | Feng et al.
Co-transfer of bulk CD4+ T cells restrains 
CBir1 Tg CD4+ T cell spontaneous 
proliferation and abrogates  
colitis development
It  has  been  shown  that  co-transfer  of  large 
numbers of CD4+ T cells into lymphopenic 
hosts restrains excessive activation and prolif-
eration of transferred CD45RBhi T cells and 
protects  the  recipient  mice  from  intestinal 
inflammation (Barthlott et al., 2003). To in-
vestigate the role of T cell spontaneous pro-
liferation in the induction of colitis, we first 
determined whether co-transfer of large numbers of irrele-
vant RAG/.OT II CD4+ T cells could control the sponta-
neous proliferation of CBir1 Tg CD4+ T cells. Both regulatory 
T (T reg) cells and competition with neighboring T cells for 
limited space and resources are involved in the inhibition of 
spontaneous proliferation (Barthlott et al., 2003; Moses et al., 
2003;  Stockinger  et  al.,  2004;  Bourgeois  and  Stockinger, 
2006; Winstead et al., 2008). T reg cells are also able to 
inhibit colitis development induced by T cells (Cong et al., 
2002; Mottet et al., 2003; Izcue et al., 2009). We used RAG/.
OT II CD4+ T cells, which are all naive and contain no T reg 
cells, to exclude the role of T reg cells in this system. 106 
CFSE-labeled CD4+ T cells from CD45.1 CBir1 Tg mice 
were co-transferred with 12 × 106 CD4+ T cells from CD45.2 
RAG/.OT II mice into RAG/ mice. 10 d later, T cell 
spontaneous proliferation in these mice was compared with 
that in the recipients receiving 106 CFSE-labeled CD45.1 
CBir1 Tg CD4+ T cells alone. When transferred alone, CBir1 
Tg CD4+ T cells proliferated massively in RAG/ mice, 
and most cells underwent spontaneous proliferation (59.3%; 
Fig. 6 A). In contrast, CBir1 Tg CD4+ T cells proliferated much 
less when transferred together with 12 × 106 RAG/.OT II 
CD4+ T cells. A smaller number of CBir1 Tg T cells under-
went spontaneous proliferation (21.2%), and most CBir1 
IL-6 mediates colitis development induced by CBir1 Tg CD4+ 
T cells in RAG/ mice
To determine whether IL-6 is also important for the induc-
tion of colitis, CBir1 Tg CD4+ T cells were transferred into 
conventional SPF RAG/ mice. A group of 5 mice were 
injected with 100 µg anti–IL-6R mAb i.p. at the time of cell 
transfer and weekly thereafter, or with control mAb as con-
trol. Treatment with anti–IL-6R mAb but not control mAb 
inhibited weight loss (Fig. 5 A). When sacrificed 8 wk after 
cell transfer, all RAG/ recipient mice treated with control 
mAb developed severe colitis, whereas only 3 out of 5 recipi-
ent mice that were treated with anti–IL-6R mAb developed 
mild colitis, and the colon of the other 2 recipient mice was 
normal (Fig. 5, B–E). The colonic LP CD4+ T cells in colitic 
recipient mice treated with control mAb produced high 
amounts of IFN- and IL-17, and a substantial proportion of 
CD4+ T cells produced both IFN- and IL-17 (Fig. 5 F). 
Blockade of IL-6 signaling dramatically inhibited colonic   
IL-17 and IFN- single-positive CD4+ T cells, as well as 
double-positive CD4+ T cells. These data indicate that IL-6 
not only mediates microbiota innate stimulation-driven CD4+ 
T cell spontaneous proliferation, but also induces colitis de-
velopment driven by CD4+ T cells reactive to microbiota 
bacterial antigens.
Figure 5.  Administration of anti–IL-6R mAb  
inhibits colitis development induced by CBir1 Tg 
CD4+ T cells in RAG/ mice. RAG/ mice were re-
constituted with 106 CBir1 Tg CD4+ T cells. Groups of 5 
recipient mice were injected with 100 µg anti–IL-6R 
mAb or control mAb i.p. weekly. A group of five recipi-
ent mice were injected i.p. with PBS as control. Recipi-
ent mice were weighed weekly. 8 wk after cell transfer, 
the mice were sacrificed and assessed for histopathol-
ogy. LP CD4+ T cell cytokine production was determined 
by flow cytometry. (A) Weight changes of the recipient 
mice. *, P < 0.05 compared with anti–IL-6R mAb–
treated mice. (B) Colonic pathology scores of the recipi-
ent mice. *, P < 0.05 compared with anti–IL-6R 
mAb–treated mice (nonparametric Mann-Whitney test). 
(C–E) Histopathology of the recipient mice. Bars, 50 µm. 
(F) Intestinal LP CD4+ T cell IL-17 and IFN- production. 
The representative experiment shown was performed 
twice with similar data.JEM VOL. 207, June 7, 2010 
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neous proliferation is a prerequisite for colitis 
development in lymphopenic hosts.
DISCUSSION
Microbiota activation of T cells plays an im-
portant role in the pathogenesis of IBD, par-
ticularly the microbiota stimulation of bacterial 
antigen-specific T cells that induce colitis 
(Lodes et al., 2004; Kieper et al., 2005; Sartor, 
2006; Strober et al., 2007; Xavier and Podolsky, 
2007; Surh and Sprent, 2008). We report 
here that beyond the well-appreciated role in 
driving pathogenic bacterial antigen-specific   
T cells via the T cell receptor, the microbiota 
also provide innate stimulation to promote T cell clonal ex-
pansion via spontaneous proliferation, which is dependent on 
innate cell IL-6 production. This microbiota-driven T cell 
spontaneous proliferation is necessary for colitis development, 
but not sufficient in itself as microbiota antigen stimulation   
to reach a threshold number of T cells producing IFN-, and 
IL-17 is also required.
Two distinct types of cell proliferation occur after adop-
tive transfer of naive T cells into lymphopenic mice. Slow 
homeostatic proliferation is IL-7 and IL-15 dependent, in 
that blockade of either IL-7 or IL-15 abrogates it (Min et al., 
2005). Rapid spontaneous proliferation is dependent on anti-
gen recognition via TCR and MHC, either by self-antigens 
or by commensal bacterial antigens (Min et al., 2005). Although 
our data demonstrated that naive CD4+ T cells underwent 
rapid spontaneous proliferation in SPF RAG/ mice but not 
in germfree RAG/ mice, which is consistent with previous 
Tg T cells remained undivided (68.5%; Fig. 6 B), indicating 
that large numbers of naive OT II T cells restrained CBir1 
Tg T cell spontaneous proliferation. Co-transfer of bulk 
OT II T cells inhibited CBir1 Tg T cell activation, in that 
the level of CD44 expression by CBir1 Tg T cells was much 
lower when co-transferred with 12 × 106 RAG/.OT II 
T cells compared with transfer of 106 CBir1 Tg T cells 
alone (Fig. 6 C).
To determine whether restraining CBir1 Tg T cell spon-
taneous proliferation affects their ability to induce colitis, re-
cipient RAG/ mice were sacrificed 8 wk after cell transfer, 
and the histopathology was determined. All RAG/ recipi-
ents that received CBir1 Tg CD4+ T cells alone developed 
severe colitis (9 out of 9), whereas the recipients that were 
co-transferred with CBir1 Tg CD4+ T cells and RAG/.
OT II T cells developed either mild or no colonic inflamma-
tion (Fig. 6, D and E). These data indicate that T cell sponta-
Figure 6.  Co-transfer of large numbers of OT II 
CD4+ T cells restrains CBir1 Tg T cell spontaneous 
proliferation and inhibits colitis induction. 106 
CFSE-CD45.1 CBir1 Tg CD4+ T cells were transferred 
into RAG/ mice alone (A) or together with 12 × 106 
CD45.2 RAG/.OT II CD4 T cells (B). 10 d after the 
transfer, division of the CFSE-labeled CBir1 Tg T cells 
was determined by CFSE dilution by gating on CD45.1+ 
cells. Numbers in each plot represent the percentage of 
donor cells undergoing spontaneous proliferation,  
homeostatic proliferation, and staying undivided,  
respectively. (C) CD44 expression of CBir1 Tg T cells was 
determined by flow cytometry by gating on CD45.1+ 
cells. Data are from one of two independent experi-
ments with similar results. (D) The recipient mice were 
sacrificed 8 wk after cell transfer and the total pathol-
ogy score of cecum and large intestine was assessed.  
*, P < 0.05 compared with the group that received 
CBir1 Tg T cells and bulk OT II T cells (nonparametric 
Mann-Whitney test). Data are sum of two independent  
experiments. (E) Histopathology of colon in the  
recipient mice. Bars: (E, left) 100 μm; (E, middle and  
right) 50 μm. The representative experiment shown  
was performed twice with similar data.1328 Microbiota innate stimulation in colitis | Feng et al.
RAG/ mice than did OT II T cells specific for OVA, 
which is not present in the intestinal lumen. Also, although 
transfer of CBL-pulsed BMDCs rescued OT II T cell spon-
taneous proliferation in germfree RAG/ mice to a compa-
rable level to OT II T cell spontaneous proliferation in SPF 
RAG/ mice, it was still reduced compared with flagellin-
specific CBir1 Tg T cells in SPF RAG/ mice. This is consis-
tent with antigenic stimulation by microbiota further promoting 
T cell clonal expansion, which is initiated by the innate stim-
ulation of microbiota.
How important is microbiota-driven T cell spontaneous 
proliferation in the pathogenesis of colitis? It has long been 
speculated that lymphopenia-induced homeostatic prolifera-
tion plays an important role in the pathogenesis of autoim-
mune diseases (Theofilopoulos et al., 2001; King et al., 2004; 
Krupica et al., 2006; Milner et al., 2007; Chang et al., 2008; 
McPherson et al., 2009). In an experimental model of auto-
immune retinitis, autoimmune disease in the retina occurs 
only with lymphopenia-induced proliferation of naive CD4 
T cells (McPherson et al., 2009). Furthermore, germline mu-
tation of Foxp3 in scurfy mice causes lymphopenia in the 
spleen and massive T cell spontaneous proliferation in neo-
nates, which together with the T reg cell defect leads to fatal 
autoimmune disease (Chang et al., 2008). As shown in Fig. 6, 
CBir1 Tg T cells underwent massive spontaneous prolifera-
tion and induced colitis in RAG/ mice. Consistent with a   
observations (Kieper et al., 2005), we show that reconsti-
tution with BMDCs pulsed with CBLs from conventional   
SPF mice restored spontaneous proliferation of adoptively 
transferred OT II CD4+ T cells in germfree RAG/ mice. 
These data indicate that the microbiota promotes T cell 
spontaneous proliferation in lymphopenic mice, in part, via 
innate stimulation rather than antigen stimulation. Interestingly, 
reconstitution of germfree RAG/ mice with CBL-pulsed 
IL-6/ BMDCs failed to restore spontaneous proliferation 
of CD4+ T cells, confirming a crucial role of IL-6 in sponta-
neous proliferation. Our results are in line with a recent study 
which demonstrated an important role of IL-6 in CD8+  
T cell spontaneous proliferation in lymphopenic mice (Tajima 
et al., 2008). Microbiota CBLs stimulated BMDCs to pro-
duce IL-6 predominantly via Myd88, in that Myd88 defi-
ciency impaired CBL-stimulated DC IL-6 production in 
vitro and in vivo. Although our data definitely indicate an 
involvement of Myd88 to induce IL-6 production, the 
Myd88 pathway is complex and many different cell processes 
are affected by this mutation, thus other factors could also 
contribute to this process. Collectively, these data indicate 
that T cell spontaneous proliferation in lymphopenic mice is 
predominantly driven by microbiota TLR ligand–stimulated 
innate cell IL-6 production. Notably, CBir1 Tg T cells spe-
cific for a bacterial flagellin present in the intestinal lumen 
underwent more extensive spontaneous proliferation in SPF 
Figure 7.  Two-hit model of the role of microbiota in the pathogenesis of colitis. (1) Microbiota stimulates intestinal innate cell IL-6 production 
through TLR–TLR ligand interactions. IL-6, and probably other factors, promotes spontaneous proliferation of T cells, which are in T0 status and do not 
produce effector cytokines. (2) Once T0 cells encounter their cognate microbiota antigen, they will proliferate in a TCR-dependent matter and differentiate 
into effector T cells, which produce effector cytokines IFN- and IL-17 locally in the colon and induce inflammation.JEM VOL. 207, June 7, 2010 
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CBir1 Tg T cells in both small and large intestinal LP. Inter-
estingly, the bacteria that produce CBir1-like flagellins (Duck 
et al., 2007) are only detected in the cecum and colon but 
not in the small intestine (unpublished data). Collectively, 
these data indicate that both microbiota innate stimulation-
driven T cell spontaneous proliferation and microbiota anti-
gen-induced TCR activation are required for the induction 
of colitis.
Microbiota stimulation of innate IL-6 production could 
have more than one function in driving colitis development. 
IL-6 promotes T cell spontaneous proliferation and is re-
quired for induction of Th17 cells. Th17 cell response has 
been implicated in patients with Crohn’s disease and in ex-
perimental colitis. Blockade of Th17 pathway by administra-
tion of anti–IL-23 or anti–IL-23R antibodies inhibited colitis 
development in immunodeficient mice adoptively transferred 
with cecal bacterial antigen-specific T cells or CD4+CD45RBhi 
T cells (Elson et al., 2007; Lee et al., 2009). IL-6 acts as a 
crucial cytokine in driving Th17 cell differentiation together 
with TGF. Thus, innate IL-6 production stimulated by the 
microbiota may stimulate Th17 cells in the intestine. In addi-
tion to substantial numbers of IFN-+ CD4+ T cells and   
IL-17+ CD4+ T cells, large numbers of IFN-+IL-17+ CD4+   
T cells were also present in the colonic LP of colitic RAG/ 
recipient mice of CBir1 Tg T cells, but not in the RAG/ 
recipient mice of OT II T cells, indicating that both IL-6 and 
TCR activation are required to generate these IFN-+IL-17+ 
CD4+ T cells. It has been shown recently that Th17 cells can 
convert into IFN-–producing Th1 cells both in vitro and in 
vivo (Lee et al., 2009; Yang et al., 2008), but there is no evi-
dence showing Th1 cell conversion to Th17 cells. A recent 
study using genome-wide mapping of H3K4me3, a permis-
sive histone modification found at promoters and enhancers 
of active genes, and H3K27me3, which is present in broad 
domains that encompass inactive genes, indicates that both 
Rorc and IL-17 gene loci have repressive hallmarks in Th1 
cells. This suggests that it may be more difficult to induce 
IL-17 production in a polarized Th1 cell (Wei et al., 2009). 
The blockade of IL-6 inhibited both Th17 cell development 
and the generation of IFN-+IL-17+ CD4+ T cells. Thus, 
IFN-+IL-17+CD4+ T cells could represent the transition stage 
of Th17 conversion to Th1 cells.
In summary, our data demonstrate that microbiota stimu-
lation of innate cell IL-6 production via Myd88 drives T cell 
spontaneous proliferation. Such T cell spontaneous prolifera-
tion is necessary but not sufficient for the induction of colitis 
in immunodeficient mice, which also requires further stimu-
lation of T cell receptors by antigens of the microbiota. These 
data are consistent with a two-hit model of the role of micro-
biota in the pathogenesis of colitis. First, microbiota pro-
motes T cell clonal expansion by stimulating spontaneous 
proliferation  through  innate  IL-6  production.  Second,   
T cells must encounter their cognate microbiota antigen, 
which further stimulates antigen-specific T cell activation 
and effector T cell differentiation to drive the development 
of colitis (Fig. 7).
previous study by Barthlott et al. (2003), co-transfer of large 
numbers of OT II T cells inhibited CBir1 Tg T cell sponta-
neous proliferation through homeostatic regulation. Interest-
ingly, inhibition of CBir1 Tg T cell spontaneous proliferation 
also abrogated colitis induction by CBir1 Tg T cells in 
RAG/  mice,  which  provides  direct  evidence  for  the   
requirement for T cell spontaneous proliferation in the in-
duction of colitis in this transfer model. In line with this ar-
gument, it has been shown that colitis development in mice 
with  myeloid-specific  STAT3  deficiency  is  abrogated  in 
TLR4-deficient mice (Kobayashi et al., 2003), and intesti-
nal inflammation in IL-10/ mice is abolished by concom-
itant Myd88 deficiency (Rakoff-Nahoum et al., 2006), both 
of which might be caused by the lack of spontaneous prolif-
eration  driven  by  microbiota  stimulation  on  innate  cells   
in the gut. How bulk OT II T cells inhibit CBir1 Tg T cell 
spontaneous proliferation is currently unknown, but com-
petition for DC occupancy, availability of cytokines, and 
limited space are potentially involved. It is also unknown 
whether bulk OT II T cell inhibition of CBir1 Tg T cell–
induced colitis is caused by inhibition of CBir1 Tg T cell 
activation or proinflammatory cytokine production in addi-
tion to inhibition of CBir1 Tg T cell spontaneous prolif-
eration. The mechanism of such inhibition is under active 
investigation.
An enhanced T cell response to microbiota antigens has 
been demonstrated in patients with IBD, as well as in multi-
ple  experimental  colitis  models  (Duchmann  et  al.,  1995; 
Cong et al., 1998; Blumberg et al., 1999). Adoptive transfer 
of CD4+ T cells reactive to cecal bacterial antigens, or even 
to a single commensal antigen, CBir1 flagellin, induced coli-
tis in immunodeficient mice (Lodes et al., 2004). Our current 
data further emphasize the importance of microbiota antigen 
stimulation of specific CD4+ T cells in driving colitis devel-
opment. Both CBir1 Tg T cells and OT II T cells underwent 
rapid spontaneous proliferation in RAG/ recipient mice; 
however, only CBir1 Tg T cells, which are reactive to a mi-
crobiota  flagellin  present  in  the  intestinal  lumen,  induced 
colitis development. OT II T cells underwent spontaneous 
proliferation but did not induce colitis in RAG/ mice. 
However,  if  the  RAG/  recipient  mice  were  colonized 
with OVA-expressing E. coli in the intestine, but not with   
E. coli that express an irrelevant Tetanus toxin fragment C 
antigen, OT II CD4+ T cells were able to induce colitis in 
RAG/ recipient. This is consistent with the previous re-
port that adoptive transfer of BALB/c.DO11.10 Th1 and 
Th2 cells, which are also specific for OVA, into BALB/
c.SCID mice, did not induce colitis in the recipient mice. 
However, they were able to induce colitis in SCID recipients 
if the SCID recipient mice were colonized with OVA- 
expressing E. coli in the intestine, but not with E. coli that ex-
press  an  irrelevant  TET  antigen  (Iqbal  et  al.,  2002).  An 
interesting feature of CBir1 Tg T cell adoptive transfer model, 
as well as most other experimental colitis models, is that 
CD4+ T cells only induce inflammation in the cecum and 
colon, but not in the small intestine, despite the presence of 1330 Microbiota innate stimulation in colitis | Feng et al.
were stained with hematoxylin and eosin. All slides were scored by an expe-
rienced veterinary pathologist (T. Schoeb, University of Alabama, Birming-
ham,  AL)  without  knowledge  of  their  origin.  Histological  scoring  was 
performed using a modification of the previously reported scoring system 
(Iqbal et al., 2002). In brief, longitudinal sections were examined for crypt 
epithelial hyperplasia, degeneration, loss; goblet cell loss; crypt exudate; LP 
and submucosal inflammatory cell accumulation; submucosal edema; muco-
sal ulceration; and transmural inflammation, with the identity of specimens 
concealed from the pathologist. Each lesion component was scored 1, 2, 
or 3 for mild, moderate, or severe, respectively (intensity), and 0 for ab-
sent, or 1, 2, 3, or 4 for 25, 50, 75, or 100% of the tissue affected,   
respectively (extent). The total lesion severity score was calculated by summa-
tion of the products of extent and intensity scores for each individual   
lesion component.
Statistical analysis. The nonparametric Mann-Whitney U test was used. 
The differences were considered statistically significant at P < 0.05.
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Mice. C57BL/6 (B6) mice, B6.OT II mice, B6.IL-6/ mice, B6.Myd88/ 
mice, and B6.RAG-1/ mice were obtained from The Jackson Laboratory 
and maintained in the Animal Facility at the University of Alabama at Bir-
mingham (UAB). B6.RAG-1/.OT II mice were obtained from Taconic. 
B6.CBir1-specific TCR transgenic (CBir1 Tg) mice were generated and 
maintained in the Animal Facility at UAB (Cong et al., 2009). Germfree 
B6.RAG-1/ mice were derived by hysterectomy and maintained in Trex-
ler type isolators according to standard gnotobiotic techniques using germ-
free SW mice (Taconic) as foster mothers (Trexler, 1983). Isolators were 
monitored  for  contamination  monthly  by  examination  of  Gram-stained 
films of fresh fecal samples and by aerobic and anaerobic bacterial culture and 
fungal culture of fresh fecal samples and swabs of water bottle sipper tubes 
and isolator interiors. ASF was established to generate ASF B6.RAG-1/ 
mice according to Taconic’s instructions and confirmed by examination of 
Gram-stained films of fresh fecal samples. 8–10-wk-old female mice were 
used in these experiments. All experiments were reviewed and approved by 
the Institutional Animal Care and Use Committee of UAB.
Reagents and materials. Reagents and materials were purchased from the 
following sources: anti–mouse CD4, IL-17, IFN-, CD45.1, and CD 44 
antibodies were purchased from BD; DNase and collagenase type IV were 
purchased from Sigma-Aldrich; CFSE was purchased from Invitrogen; and 
GM-CSF was purchased from R&D Systems.
CD4+ T cell purification and labeling with CFSE. CD4+ T cells were 
isolated as previously described (Elson et al., 2007) by using anti–mouse 
CD4-magnetic beads (BD). For some experiments, CD4+ T cells were la-
beled with 2.5 µM CFSE following manufacture’s protocol at 37°C in the 
presence of 0.1% BSA.
Generation of BMDCs. BM cells were isolated as described previously 
(Elson et al., 2007) by culturing BM cells in the presence of 20 ng/ml GM-
CSF in 6-well plates (Corning) at 37°C in 5% CO2 in humid air for 8 d.
Isolation of LP cells. Small and large intestines were removed, sliced, and 
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EDTA and 2% FBS for 40 min at 37°C, the tissue was resuspended in diges-
tion medium containing RPMI 1640, 5% FBS, 0.5 mg/ml collagenase type 
IV, and 10 µg/ml DNase, and then incubated for 40 min at 37°C by gentle 
shaking two times. Cells were passed through a mesh, centrifuged, and the 
pellet was resuspended in 40% Percoll and carefully overlaid onto 70% Per-
coll. The interface containing the LP leukocytes was collected and washed 
with PBS supplemented with 1% FBS.
Intracellular staining for cytokine production. As described previously 
(Elson et al., 2007), 5 × 105 cells were stimulated for 5 h with PMA and ion-
omycin. Monensin was added for the last 3 h of culture. After surface stain-
ing for CD4, the cells were fixed and permeabilized using Cytofix/Cytoperm 
solution (BD). IL-17 and IFN- staining was done by using PE- or APC-
conjugated antibodies (BD).
Adoptive transfer of OT II and CBir1 Tg T cells and induction of 
colitis. As previously described, CFSE-labeled or unlabeled CD4+ T cells 
were injected i.v. into groups of five RAG/ mice housed in SPF or germ-
free condition. In some experiments, certain groups of the OT II T cell re-
cipients were given OVA-expressing E. coli or TET-expressing E. coli into 
the colon weekly. OVA-expressing E. coli and TET-expressing E. coli were 
generated as described previously (Iqbal et al., 2002). 2 mo later, the mice 
were sacrificed and histopathology was examined.
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